Lineage Cell Therapeutics holds annual meeting; all director nominees elected, auditor ratified, say-on-pay approved

Lineage Cell Therapeutics, Inc.

Elected nine directors: Kingsley, Amin, Andrews, Bailey, Bradsher, Culley, Jayasuriya, Mulroy, Russell.
Ratified WithumSmith+Brown as auditor: 114.8M for, 0.5M against, 1.4M abstain.
Advisory say-on-pay approved: 70.9M for, 1.8M against, 1.8M abstain.
Broker non-votes of 42.2M on director elections and say-on-pay.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.